Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues (LLY)
July 16, 2013 at 11:30 AM EDT
Eli Lilly & Co. (NYSE: LLY ) planned to go back to the drawing board with its new experimental Alzheimer’s drug, according Bloomberg . The drug, solanezumab, which was not successful with advanced Alzheimer’s patients, will be tested in patients who show signs of early stages of the disease. Using
